We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
-1.18%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$4.86B
AUM Growth
+$362M
Cap. Flow
+$499M
Cap. Flow %
10.26%
Top 10 Hldgs %
17.76%
Holding
548
New
154
Increased
98
Reduced
117
Closed
170

Top Buys

Rank Stock Value
1
CRR
Carbo Ceramics Inc.
CRR
+$50.9M
2
BHI
Baker Hughes
BHI
+$50M
3
SHPG
Shire pic
SHPG
+$49.7M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$49.3M
5
MLM icon
Martin Marietta Materials
MLM
+$42.5M

Top Sells

Rank Stock Value
1
AMSG
Amsurg Corp
AMSG
+$72.9M
2
VISN
Vistance Networks Inc
VISN
+$35.4M
3
TKR icon
Timken Company
TKR
+$34.1M
4
QCOR
QUESTCOR PHARMA INC
QCOR
+$33.8M
5
DHR icon
Danaher
DHR
+$33.6M

Sector Composition

Rank Sector Weight
1 Healthcare 12.84%
2 Financials 10.91%
3 Industrials 10.79%
4 Energy 9.19%
5 Consumer Discretionary 8.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ARDX icon
326
Ardelyx
ARDX
$997M
$1M 0.02%
70,633
-55,558
-44% -$803K
FOMX
327
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$995K 0.02%
+182,609
New +$1.05M
SVRA icon
328
CALL
Savara
SVRA
$1.19B
$989K 0.02%
25,357
– –
ZPIN
329
DELISTED
Zhaopin Limited
ZPIN
$973K 0.02%
75,000
+24,524
+49% +$356K
TRVN
330
DELISTED
Trevena, Inc.
TRVN
$965K 0.02%
240
-121
-34% -$456K
ZSPH
331
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
$939K 0.02%
23,930
-87,742
-79% -$2.9M
KYTH
332
DELISTED
KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH
$928K 0.02%
+28,342
New +$998K
INNL
333
DELISTED
Innocoll Holdings plc Ordinary Shares
INNL
$900K 0.02%
+136,422
New +$1.11M
VTSS
334
DELISTED
VITESSE SEMICONDUCTOR CORPORATION COMMON STOCK
VTSS
$900K 0.02%
250,000
-397,639
-61% -$1.29M
ASPX
335
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
$895K 0.02%
+34,856
New +$742K
DRNA
336
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$871K 0.02%
+68,406
New +$1.03M
SUPN icon
337
Supernus Pharmaceuticals
SUPN
$2.77B
$865K 0.02%
+99,547
New +$899K
IMDZ
338
DELISTED
Immune Design Corp.
IMDZ
$827K 0.02%
+46,833
New +$593K
ITCI
339
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$823K 0.02%
59,995
-65,498
-52% -$984K
OPWR
340
DELISTED
OPOWER INC COM STK (DE)
OPWR
$814K 0.02%
43,144
-43,317
-50% -$729K
EVAR
341
DELISTED
Lombard Medical, Inc.
EVAR
$801K 0.02%
104,109
-4,925
-5% -$32.6K
ARGS
342
DELISTED
Argos Therapeutics, Inc.
ARGS
$799K 0.02%
3,972
-2,790
-41% -$436K
IMPR
343
DELISTED
IMPRIVATA, INC COM
IMPR
$776K 0.02%
50,000
-13,095
-21% -$193K
RLJE
344
CALL
DELISTED
RLJ Entertainment, Inc.
RLJE
$774K 0.02%
66,667
– –
TRUP icon
345
Trupanion
TRUP
$1.18B
$748K 0.02%
+88,020
New +$815K
CVRR
346
DELISTED
CVR Refining, LP
CVRR
$738K 0.02%
31,680
– –
ALDR
347
DELISTED
Alder Biopharmaceuticals
ALDR
$722K 0.01%
56,937
+18,193
+47% +$275K
NGNE icon
348
Neurogene
NGNE
$712M
$704K 0.01%
5,282
-250
-5% -$38.1K
GEVO icon
349
CALL
Gevo
GEVO
$382M
$685K 0.01%
333
+216
+185% +$718K
NSLR
350
Neostellar Capital Corp
NSLR
$254M
$673K 0.01%
103,578
-4,899
-5% -$32.6K
12 13
14
15 16

Similar funds

Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
SAM
Storebrand Asset Management Lysaker, Norway $34.8B AUM 25.49% 1-Year Est. Return
Chevy Chase Trust
Chevy Chase Trust Bethesda, Maryland $34.7B AUM 29.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
VIA
Vanguard Investments Australia Victoria, Australia $34.6B AUM
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

Alyeska Investment Group's Q3 2014 Portfolio in Review

As of Q3 2014, Alyeska Investment Group held 548 positions worth $4.86B, up 8% from $4.5B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Alyeska Investment Group deployed $499M of net new capital in Q3 2014, opening 154 new positions and adding to 98 existing holdings. Its largest new stake was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Vistance Networks Inc, an estimated $35.4M trimmed.

  • Alyeska Investment Group's largest Q3 2014 buy was Carbo Ceramics Inc.: 446,143 shares worth $26.4M.
  • Alyeska Investment Group added most to DIRECTV COM STK (DE) in Q3 2014, an estimated $38.9M increase.
  • Alyeska Investment Group's biggest Q3 2014 reduction was Vistance Networks Inc, cutting an estimated $35.4M.
  • Alyeska Investment Group fully exited Amsurg Corp in Q3 2014, selling an estimated $72.9M.
  • Alyeska Investment Group's ten largest holdings make up 18% of its $4.86B portfolio in Q3 2014.
  • Alyeska Investment Group opened 154 new positions and closed 170 in Q3 2014.
  • Alyeska Investment Group's portfolio value rose 8% quarter-over-quarter to $4.86B.

Based on Alyeska Investment Group's 13F filing for Q3 2014, filed 14 Nov 2014.